Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osteotech Tissue Recall Traced To Equipment Malfunction In Electrical Storm

This article was originally published in The Gray Sheet

Executive Summary

Osteotech is testing the rework procedure it developed to resterilize recalled and quarantined donor tissue and hopes to have the procedure validated and in place by year-end

You may also be interested in...

CDRH Examining CryoLife Heart Valve Risks Following Tissue Recall

CDRH is reviewing potential risks associated with CryoValve heart valves in the wake of an Aug. 14 recall order for CryoLife human tissue products

FDA Tissue Registration Rule Clarifies Classification Of Combination Devices

Manufacturers of combination devices incorporating human cells or tissues will have until Jan. 19, 2003 to register with FDA, according to a final rule released by the agency Jan. 18.

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts